Phase III trial of doxorubicin plus cyclophosphamide (AC), docetaxel, and alternating AC and docetaxel as front-line chemotherapy for metastatic breast cancer: Japan Clinical Oncology Group trial (JCOG9802) - Annals of Oncology
Chemotherapy for Uterus Cancer
BIG against BC on Twitter: "#APHINITYtrial is a phase III adjuvant study investigating the benefit of pertuzumab when added to trastuzumab + # chemotherapy #SABCS19 #OncoAlert https://t.co/AkL68wNO02" / Twitter
IJMS | Free Full-Text | Expression of Human Endogenous Retrovirus env Genes in the Blood of Breast Cancer Patients | HTML
Chemotherapy Protocol
Increasing the dose intensity of chemotherapy by more frequent administration or sequential scheduling: a patient-level meta-analysis of 37 298 women with early breast cancer in 26 randomised trials - The Lancet
AC Chemotherapy Regimen | Living Beyond Breast Cancer
PDF) Dose Dense Doxorubicin and Cyclophosphamide Followed by Paclitaxel (Dose Dense AC Followed by T) Regimen for Breast Cancer
Adjuvant chemotherapy of breast cancer
Anthracycline-free or short-term regimen as adjuvant chemotherapy for operable breast cancer: A phase III randomized non-inferiority trial - The Lancet Regional Health – Western Pacific
Dose-dense adjuvant chemotherapy in node-positive breast cancer: docetaxel followed by epirubicin/cyclophosphamide (T/EC), or the reverse sequence (EC/T), every 2 weeks, versus docetaxel, epirubicin and cyclophosphamide (TEC) every 3 weeks. AERO B03 ...
CONSORT diagram for Alliance/Cancer and Leukemia Group B 49907 trial.... | Download Scientific Diagram
Outcomes after neoadjuvant or adjuvant chemotherapy for cT2-4N0-1 non–small cell lung cancer: A propensity-matched analysis - The Journal of Thoracic and Cardiovascular Surgery
Dose Dense Doxorubicin and Cyclophosphamide Followed by Paclitaxel... | Download Table
Progress of patients through the study. AC-DOC, sequential schedule of... | Download Scientific Diagram
PERSEPHONE: are we ready to de-escalate adjuvant trastuzumab for HER2-positive breast cancer? | npj Breast Cancer
Weekly dose-dense chemotherapy in first-line epithelial ovarian, fallopian tube, or primary peritoneal carcinoma treatment (ICON8): primary progression free survival analysis results from a GCIG phase 3 randomised controlled trial - The Lancet
BreastCancerUpdate.com - Clinical Trials
Breast Cancer Update .com - Web Guide 1 2003
Standardizing Chemotherapy Regimen Nomenclature: A Proposal and Evaluation of the HemOnc and National Cancer Institute Thesaurus Regimen Content | JCO Clinical Cancer Informatics
Update on systemic treatment for newly diagnosed inflammatory breast cancer - ScienceDirect
Chemotherapy protocol definition form | Download Scientific Diagram
